<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00854386</url>
  </required_header>
  <id_info>
    <org_study_id>TASMC-08-IM-0502-CTIL</org_study_id>
    <nct_id>NCT00854386</nct_id>
  </id_info>
  <brief_title>Effect of Intraoperative Fluid Restriction on Postoperative Outcomes in Video-assisted Thoracic Surgery (VATS)</brief_title>
  <official_title>The Effect of Intraoperative Fluid Restriction on Postoperative Outcomes in Video-assisted Thoracic Surgery (VATS) for Lung Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to compare the effects of two intraoperative fluid regimens -
      restrictive versus liberal (standard)- on postoperative outcomes (e.g. cardiopulmonary
      complications, morbidity, mortality and duration of hospitalization) in lung resections via
      Video-assisted thoracic surgery (VATS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Working hypothesis and aims:

      The aim of this study is to investigate the effect of restrictive versus standard
      intraoperative fluid regimen on cardiopulmonary mordibity and mortality after VATS for lung
      resection. Our study hypothesis is that restrictive intraoperative fluid administration in
      patients undergoing VATS, will lead to better outcomes compared to a liberal fluid regimen.

      Methods:

      After obtaining informed consent, patients will be randomly assigned to one of two
      groups—liberal-protocol group (LG) or restricted-protocol group (RG). Anesthetic and surgical
      management will be performed similarly and according to standards for both groups, with one
      exception: patients in the RG group will receive 2 ml/kg•hr whereas patients in the RL group
      will receive 8 ml/kg•hr of Ringer Lactate (RL) solution throughout the intraoperative period.
      Hemodynamic changes during this period will be treated pharmacologically unless indicated
      otherwise. Blood loss, in both groups, will be replaced with RL solution in a 3:1 volume
      replacement, and blood and/or blood products will be transfused when required.
      Postoperatively, pain and fluid management will be standardized for both groups, according to
      departmental routines. Patient assessment will be performed by a blinded assessor. The
      primary endpoints of the study will combine: the incidence of post-operative complications
      (pulmonary, cardiovascular, others), re-intubations, and readmitions to the ICU during
      primary hospitalization; number of patients readmitted to the hospital within 30 days of
      surgery.

      The secondary endpoints will include length of hospital stay, differences in hematocrit,
      urea, creatinine concentrations and oxygen saturation immediately postoperatively, in the
      first and third postoperative days and with discharge, and the number of patients receiving
      transfusion of blood and blood products; time to extubation, time to sit/stand/walk/eat/drink
      (recovery data).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2009</start_date>
  <completion_date type="Anticipated">September 2011</completion_date>
  <primary_completion_date type="Anticipated">May 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiopulmonary complications</measure>
    <time_frame>30 postoperative days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>30 postoperative days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Acute Lung Injury (ALI)</condition>
  <condition>Acure Respiratory Distress Syndrome (ARDS)</condition>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>liberal fluid administration group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Restrictive fluid administration group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>liberal fluid administration</intervention_name>
    <description>patients in the liberal group (LG) will receive 8 ml/kg•hr of ringer lactate (RL) solution</description>
    <arm_group_label>1</arm_group_label>
    <other_name>liberal</other_name>
    <other_name>standard</other_name>
    <other_name>control</other_name>
    <other_name>high volume</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>restrictive fluid administration</intervention_name>
    <description>Patients in the restrictive group (RG) will receive 2 ml/kg•hr of Ringer Lactate (RL) solution throughout the intraoperative period</description>
    <arm_group_label>2</arm_group_label>
    <other_name>restrictive</other_name>
    <other_name>experimental</other_name>
    <other_name>low volume</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years old, with ASA I-III, undergoing elective VATS for lobectomy (of at
             least 2 segments), segmentectomy or pneumonectomy in the Sourasky Medical Center.

        Exclusion Criteria:

          -  Patients with a history of chronic renal insufficiency (creatinine &gt; 1.5 of normal
             value), congestive heart failure or hepatic dysfunction.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Months</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Idit Matot, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tel-Aviv Sourasky Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Idit Matot, Prof</last_name>
    <phone>97236974758</phone>
    <email>iditm@tasmc.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yifat Klein, PhD</last_name>
    <phone>97236974093</phone>
    <email>yifat.klein@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tel Aviv Sourasky medical center</name>
      <address>
        <city>Tel aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julia Rivo, MD</last_name>
      <phone>97236974093</phone>
      <email>juliarivo@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Yifat Klein, PhD</last_name>
      <phone>97236974093</phone>
      <email>yifat.klein@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Yifat Klein, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julia Rivo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yifat Klein, PhD</last_name>
      <phone>97236974093</phone>
      <email>yifat.klein@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Nisanevich V, Felsenstein I, Almogy G, Weissman C, Einav S, Matot I. Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology. 2005 Jul;103(1):25-32.</citation>
    <PMID>15983453</PMID>
  </reference>
  <reference>
    <citation>Licker M, de Perrot M, Spiliopoulos A, Robert J, Diaper J, Chevalley C, Tschopp JM. Risk factors for acute lung injury after thoracic surgery for lung cancer. Anesth Analg. 2003 Dec;97(6):1558-65.</citation>
    <PMID>14633519</PMID>
  </reference>
  <reference>
    <citation>Slinger PD. Acute lung injury after pulmonary resection: more pieces of the puzzle. Anesth Analg. 2003 Dec;97(6):1555-7.</citation>
    <PMID>14633517</PMID>
  </reference>
  <reference>
    <citation>Arieff AI. Fatal postoperative pulmonary edema: pathogenesis and literature review. Chest. 1999 May;115(5):1371-7. Review.</citation>
    <PMID>10334155</PMID>
  </reference>
  <reference>
    <citation>Alam N, Park BJ, Wilton A, Seshan VE, Bains MS, Downey RJ, Flores RM, Rizk N, Rusch VW, Amar D. Incidence and risk factors for lung injury after lung cancer resection. Ann Thorac Surg. 2007 Oct;84(4):1085-91; discussion 1091.</citation>
    <PMID>17888952</PMID>
  </reference>
  <reference>
    <citation>Brandstrup B, Tønnesen H, Beier-Holgersen R, Hjortsø E, Ørding H, Lindorff-Larsen K, Rasmussen MS, Lanng C, Wallin L, Iversen LH, Gramkow CS, Okholm M, Blemmer T, Svendsen PE, Rottensten HH, Thage B, Riis J, Jeppesen IS, Teilum D, Christensen AM, Graungaard B, Pott F; Danish Study Group on Perioperative Fluid Therapy. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg. 2003 Nov;238(5):641-8.</citation>
    <PMID>14578723</PMID>
  </reference>
  <reference>
    <citation>Holte K, Klarskov B, Christensen DS, Lund C, Nielsen KG, Bie P, Kehlet H. Liberal versus restrictive fluid administration to improve recovery after laparoscopic cholecystectomy: a randomized, double-blind study. Ann Surg. 2004 Nov;240(5):892-9.</citation>
    <PMID>15492573</PMID>
  </reference>
  <reference>
    <citation>Weissberg D, Schachner A. Video-assisted thoracic surgery--state of the art. Ann Ital Chir. 2000 Sep-Oct;71(5):539-43. Review.</citation>
    <PMID>11217470</PMID>
  </reference>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2009</study_first_submitted>
  <study_first_submitted_qc>March 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 3, 2009</study_first_posted>
  <last_update_submitted>October 14, 2009</last_update_submitted>
  <last_update_submitted_qc>October 14, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 15, 2009</last_update_posted>
  <responsible_party>
    <name_title>Prof Idit Matot, director Anesthesiology and intensive care unit</name_title>
    <organization>Tel Aviv sourasky medical center</organization>
  </responsible_party>
  <keyword>fluid management</keyword>
  <keyword>VATS</keyword>
  <keyword>ALI</keyword>
  <keyword>ARDS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Lung Injury</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

